Latest News
Meta Platforms Inc. (NASDAQ:META) reports earnings tomorrow. Stock has soared 27% in past year but down 8% YTD. Technical indicators mixed, but ad strength may boost stock. Will track signals post-earnings.
Via Benzinga · April 29, 2025
The company also reported light sales, thanks to declining sales of key products like Eliquis and Ibrance.
Via Investor's Business Daily · April 29, 2025
American Tower reported first-quarter revenue of $2.56 billion, beating analyst estimates of $2.54 billion, according to estimates from Benzinga Pro. The company reported adjusted funds from operations (AFFO) of $2.75 per share, beating estimates of $2.58 per share.
Via Benzinga · April 29, 2025
Shift4 stock rose despite a Q1 earnings miss as other key metrics beat estimates.
Via Investor's Business Daily · April 29, 2025
Via The Motley Fool · April 29, 2025
Traders should be cautious, watching for volume increases and confirmation setups that could validate the unfolding of wave 3.
Via Talk Markets · April 29, 2025
STRIDE INC was identified as a growth stock that isn't overvalued. NYSE:LRN is excelling in various growth indicators while maintaining a solid financial footing.
Via Chartmill · April 29, 2025
General Motors (NYSE: GM) recalls over 877,000 vehicles due to engine defects, amid ongoing NHTSA investigation.
Via Benzinga · April 29, 2025
Glass and electronic component manufacturer Corning (NYSE:GLW) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 16% year on year to $3.45 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $3.85 billion at the midpoint, or 5% above analysts’ estimates. Its non-GAAP profit of $0.54 per share was 5.4% above analysts’ consensus estimates.
Via StockStory · April 29, 2025
As the U.S. and China continue to send mixed signals about the progress of their trade talks, economists at Morgan Stanley project that both nations will begin negotiations and slowly decrease tariffs on Chinese imports to 60% by the end of Q2.
Via Benzinga · April 29, 2025
Honeywell stock jumps earnings, outlook. The Dow Jones firm's planned separations are still expected next year.
Via Investor's Business Daily · April 29, 2025
The company reported a 2.3% year-over-year rise in its first-quarter revenue to $44.02 billion, exceeding an analyst estimate of $43.21 billion.
Via Stocktwits · April 29, 2025
SolarBank Corp (NASDAQ: SUUN) plans to develop 7.2 MW DC solar project in NY, eligible for incentives and aiming for $0.0971/kWh compensation.
Via Benzinga · April 29, 2025
HR outsourcing provider Insperity (NYSE:NSP) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.86 billion. Its non-GAAP profit of $1.57 per share was 22.4% below analysts’ consensus estimates.
Via StockStory · April 29, 2025
Via The Motley Fool · April 29, 2025
Via Benzinga · April 29, 2025
Discover UNIVERSAL TECHNICAL INSTITUT, an undervalued growth gem. NYSE:UTI is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.
Via Chartmill · April 29, 2025
Via Benzinga · April 29, 2025
Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 35.2% above analysts’ consensus estimates.
Via StockStory · April 29, 2025
POTUS warns of vetoing any bill that cuts Social Security or federal health programs. GOP's tax plan may target Medicaid, setting up a key 2026 debate.
Via Benzinga · April 29, 2025
BTC/USD remains stable above $94,000 with a bullish pennant hinting at a breakout toward $99,000, fueled by rising institutional demand and optimistic forecasts.
Via Talk Markets · April 29, 2025
Why the dividend investor may take a look at OSHKOSH CORP (NYSE:OSK).
Via Chartmill · April 29, 2025
Tobacco company Altria (NYSE:MO) announced better-than-expected revenue in Q1 CY2025, with sales up 11.5% year on year to $5.26 billion. Its non-GAAP profit of $1.23 per share was 3.5% above analysts’ consensus estimates.
Via StockStory · April 29, 2025
Beeline Holdings, parent company of Beeline Loans, surpasses $1B in closed loans. CEO says reaching milestone shows strength and value in challenging market.
Via Benzinga · April 29, 2025
Trucking company PACCAR (NASDAQ:PCAR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 16% year on year to $6.91 billion. Its non-GAAP profit of $1.46 per share was 7.5% below analysts’ consensus estimates.
Via StockStory · April 29, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025

100 years ago, a can of Campbell's condensed tomato soup was advertised for $0.12.
Via Talk Markets · April 29, 2025
Via The Motley Fool · April 29, 2025
Via Benzinga · April 29, 2025
Data backup provider Commvault (NASDAQ:CVLT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.2% year on year to $275 million. Guidance for next quarter’s revenue was better than expected at $268 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $1.03 per share was 11% above analysts’ consensus estimates.
Via StockStory · April 29, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Rubrik, which recently named a new Chief Transformation Officer.
Via Benzinga · April 29, 2025
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.4% year on year to $169.2 million. The company’s full-year revenue guidance of $707.5 million at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.39 per share was 11.4% above analysts’ consensus estimates.
Via StockStory · April 29, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Via Benzinga · April 29, 2025
Hardware products and merchandising solutions provider Hillman (NASDAQ:HLMN) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.6% year on year to $359.3 million. On the other hand, the company’s full-year revenue guidance of $1.54 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $0.10 per share was in line with analysts’ consensus estimates.
Via StockStory · April 29, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025
Via Benzinga · April 29, 2025
Via The Motley Fool · April 29, 2025
A fundamental analysis of (NASDAQ:ODFL): Why OLD DOMINION FREIGHT LINE (NASDAQ:ODFL) should be investigated by quality investors.
Via Chartmill · April 29, 2025
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $168 million. On the other hand, the company’s full-year revenue guidance of $753 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0 per share was in line with analysts’ consensus estimates.
Via StockStory · April 29, 2025